Literature DB >> 21454805

Nuclear β-catenin is increased in systemic sclerosis pulmonary fibrosis and promotes lung fibroblast migration and proliferation.

Anna P Lam1, Annette S Flozak, Susan Russell, Jun Wei, Manu Jain, Gökhan M Mutlu, G R Scott Budinger, Carol A Feghali-Bostwick, John Varga, Cara J Gottardi.   

Abstract

Pulmonary fibrosis is a disease that results in loss of normal lung architecture, but the signaling events that drive tissue destruction are incompletely understood. Wnt/β-catenin signaling is important in normal lung development, but whether abnormal signaling occurs in lung fibrosis due to systemic sclerosis and the consequences of β-catenin signaling toward the fibrogenic phenotype remain poorly defined. In this study, we show nuclear β-catenin accumulation in fibroblastic foci from lungs of patients with systemic sclerosis-associated advanced pulmonary fibrosis. Forced activation of β-catenin signaling in three independently derived sources of normal human lung fibroblasts promotes proliferation and migratory activities but is not sufficient to activate classic markers of fibroblast activation, such as TGF-β, type 1 collagen, α-smooth muscle actin, and connective tissue growth factor. These findings indicate that activation of β-catenin signaling in pulmonary fibroblasts may be a common feature of lung fibrosis, contributing to fibroproliferative and migratory activities associated with the disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454805      PMCID: PMC3262680          DOI: 10.1165/rcmb.2010-0113OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  53 in total

Review 1.  The myofibroblast in pulmonary fibrosis.

Authors:  Sem H Phan
Journal:  Chest       Date:  2002-12       Impact factor: 9.410

Review 2.  Molecular targets in pulmonary fibrosis: the myofibroblast in focus.

Authors:  Chris J Scotton; Rachel C Chambers
Journal:  Chest       Date:  2007-10       Impact factor: 9.410

Review 3.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.

Authors:  A L Katzenstein; J L Myers
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

4.  Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis.

Authors:  Marco Chilosi; Venerino Poletti; Alberto Zamò; Maurizio Lestani; Licia Montagna; Paola Piccoli; Serena Pedron; Manuela Bertaso; Aldo Scarpa; Bruno Murer; Alessandra Cancellieri; Roberta Maestro; Gianpietro Semenzato; Claudio Doglioni
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

5.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

6.  beta-Catenin is required for specification of proximal/distal cell fate during lung morphogenesis.

Authors:  Michael L Mucenski; Susan E Wert; Jennifer M Nation; David E Loudy; Joerg Huelsken; Walter Birchmeier; Edward E Morrisey; Jeffrey A Whitsett
Journal:  J Biol Chem       Date:  2003-07-28       Impact factor: 5.157

Review 7.  Proximal events in Wnt signal transduction.

Authors:  Stephane Angers; Randall T Moon
Journal:  Nat Rev Mol Cell Biol       Date:  2009-07       Impact factor: 94.444

Review 8.  WNT and beta-catenin signalling: diseases and therapies.

Authors:  Randall T Moon; Aimee D Kohn; Giancarlo V De Ferrari; Ajamete Kaykas
Journal:  Nat Rev Genet       Date:  2004-09       Impact factor: 53.242

9.  Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis.

Authors:  Annie Pardo; Kevin Gibson; José Cisneros; Thomas J Richards; Yinke Yang; Carina Becerril; Samueal Yousem; Iliana Herrera; Victor Ruiz; Moisés Selman; Naftali Kaminski
Journal:  PLoS Med       Date:  2005-09-06       Impact factor: 11.069

10.  Functional Wnt signaling is increased in idiopathic pulmonary fibrosis.

Authors:  Melanie Königshoff; Nisha Balsara; Eva-Maria Pfaff; Monika Kramer; Izabella Chrobak; Werner Seeger; Oliver Eickelberg
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

View more
  62 in total

Review 1.  Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.

Authors:  Swati Bhattacharyya; Jun Wei; John Varga
Journal:  Nat Rev Rheumatol       Date:  2011-10-25       Impact factor: 20.543

Review 2.  Canonical Wnt signaling in systemic sclerosis.

Authors:  Christina Bergmann; Jörg H W Distler
Journal:  Lab Invest       Date:  2016-01-11       Impact factor: 5.662

Review 3.  β-catenin signaling: a novel mediator of fibrosis and potential therapeutic target.

Authors:  Anna P Lam; Cara J Gottardi
Journal:  Curr Opin Rheumatol       Date:  2011-11       Impact factor: 5.006

Review 4.  Epigenetics and systemic sclerosis.

Authors:  Nezam Altorok; Bashar Kahaleh
Journal:  Semin Immunopathol       Date:  2015-07-11       Impact factor: 9.623

Review 5.  Fibrogenesis, novel lessons from animal models.

Authors:  Ellen De Langhe; Rik Lories
Journal:  Semin Immunopathol       Date:  2015-07-04       Impact factor: 9.623

6.  Nuclear α-catenin mediates the DNA damage response via β-catenin and nuclear actin.

Authors:  Leonid A Serebryannyy; Alex Yemelyanov; Cara J Gottardi; Primal de Lanerolle
Journal:  J Cell Sci       Date:  2017-03-27       Impact factor: 5.285

Review 7.  Morphogen pathways in systemic sclerosis.

Authors:  Christian Beyer; Jörg H W Distler
Journal:  Curr Rheumatol Rep       Date:  2013-01       Impact factor: 4.592

8.  Lrp5/β-Catenin Signaling Controls Lung Macrophage Differentiation and Inhibits Resolution of Fibrosis.

Authors:  Joseph A Sennello; Alexander V Misharin; Annette S Flozak; Sergejs Berdnikovs; Paul Cheresh; John Varga; David W Kamp; G R Scott Budinger; Cara J Gottardi; Anna P Lam
Journal:  Am J Respir Cell Mol Biol       Date:  2017-02       Impact factor: 6.914

9.  Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies.

Authors:  Nezam Altorok; Pei-Suen Tsou; Patrick Coit; Dinesh Khanna; Amr H Sawalha
Journal:  Ann Rheum Dis       Date:  2014-05-08       Impact factor: 19.103

10.  The Overexpression of IQGAP1 and β-Catenin Is Associated with Tumor Progression in Hepatocellular Carcinoma In Vitro and In Vivo.

Authors:  Xuewen Jin; Yuling Liu; Jingjing Liu; Weiliang Lu; Ziwei Liang; Dan Zhang; Gang Liu; Hongxia Zhu; Ningzhi Xu; Shufang Liang
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.